• SGC-CBP30: Precision CREBBP/EP300 Inhibition for Epigenetic

  2026-05-07

  Explore how SGC-CBP30, a selective CREBBP/EP300 bromodomain inhibitor, empowers advanced epigenetics and cancer biology research. Discover unique assay insights and translational implications from recent super-enhancer studies.

• Phenylmethanesulfonyl Fluoride (PMSF): Precision in Protein

  2026-05-07

  Phenylmethanesulfonyl fluoride (PMSF) empowers researchers to achieve uncompromising protein integrity during extraction and Western blot preparation. Leveraging insights from COVID-19 macrophage models, this article details actionable protocols, troubleshooting, and advanced applications for robust serine protease inhibition.

• LDH Cytotoxicity Assay Kit: Precision Cell Damage Quantifica

  2026-05-06

  The LDH Cytotoxicity Assay Kit enables precise cell cytotoxicity measurement by detecting LDH released from compromised cells. This non-radioactive assay offers reliable quantification for apoptosis detection, supporting applications from cancer research to nanomaterial biocompatibility assessment.

• SMYD2 Inhibition Attenuates Cisplatin-Induced Renal Fibrosis

  2026-05-06

  This study demonstrates that pharmacological inhibition of SMYD2, using agents such as LLY-507, significantly mitigates renal fibrosis and inflammation in a cisplatin-induced chronic kidney disease model. These findings highlight SMYD2 as a promising epigenetic target for fibrosis intervention and suggest mechanistic links to Smad3/STAT3 pathways.

• Trifluoperazine 2HCl: Applied Workflows for Dopamine D2 Inhi

  2026-05-05

  Trifluoperazine 2HCl stands out as a high-affinity dopamine D2 receptor inhibitor, enabling precise modulation of dopaminergic signaling in both neuropharmacology and immuno-oncology research. This article delivers actionable protocols, workflow enhancements, and troubleshooting strategies—maximizing experiment reproducibility and cross-domain insights.

• PLGA Nanoadjuvant Enhances Mucosal Immunity in Chick H9N2 Va

  2026-05-05

  This study introduces a PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that substantially improves both mucosal and systemic immunity in chicks vaccinated against H9N2 avian influenza. The work demonstrates the importance of intestinal targeting and sustained antigen release for effective IgA-mediated defense, with implications for next-generation vaccine design.

• EPZ-6438 in Translational Epigenetic Cancer Research: Mechan

  2026-05-04

  Explore the advanced mechanistic role of EPZ-6438 as a potent EZH2 inhibitor in epigenetic cancer research. This in-depth analysis reveals how recent breakthroughs and practical assay guidance elevate experimental design beyond standard workflows.

• Flumequine: Potent DNA Topoisomerase II Inhibitor for Resear

  2026-05-04

  Flumequine is a chemically defined, small-molecule DNA topoisomerase II inhibitor widely used in DNA replication research. Its high purity, specificity, and consistent IC50 value make it a benchmark tool for in vitro studies involving DNA damage and repair. This article details its validated applications, protocol parameters, and limitations.

• C. difficile Responses to Human Mucus: Insights from IEC Co-

  2026-05-03

  This study introduces a novel primary human intestinal epithelial cell (IEC) co-culture system that models physiologic mucus and enables detailed analysis of Clostridioides difficile's transcriptomic, metabolic, and behavioral adaptations to the mucus barrier. The findings reveal that IEC-derived mucus promotes C. difficile growth and induces distinct metabolic shifts and biofilm formation, offering a refined understanding of pathogenesis in the absence of microbiota.

• Metformin HCl Inhibits Achilles Tendon Ossification via Nr4a

  2026-05-02

  This study elucidates how Metformin Hydrochloride suppresses heterotopic ossification in mouse Achilles tendon by downregulating the Nr4a1/Wnt/β-catenin signaling axis. The findings reveal a novel non-metabolic mechanism for metformin, highlighting its potential in bone biology and pathological ossification research.

• Q-VD-OPh: Advanced Pan-Caspase Inhibition in Apoptosis Resea

  2026-05-01

  Q-VD-OPh sets the benchmark for selective, irreversible pan-caspase inhibition across diverse experimental models, enabling precise dissection of apoptotic pathways. This guide spotlights practical workflows, troubleshooting strategies, and translational use-cases—backed by recent mechanistic insights and protocol-level data.

• Thiamet G: Applied O-GlcNAcase Inhibition for Advanced Assay

  2026-05-01

  Thiamet G, a potent O-GlcNAcase inhibitor from APExBIO, enables precise modulation of O-GlcNAcylation for translational research in neurodegeneration, oncology, and placental disease. This guide delivers actionable protocols, troubleshooting, and experimental insights that maximize data quality across diverse cell and animal models.

• 2,2,2-Trichloroethanol: Precision in Dopaminergic Neuron & P

  2026-04-30

  Explore the unique role of 2,2,2-Trichloroethanol as a small molecule biochemical for advanced molecular biology and dopaminergic neuron research. This article offers a deeper look at assay decision-making, bridging protein and neurobiology workflows.

• Sildenafil Citrate: Protocols and Pitfalls in cGMP Signaling

  2026-04-30

  Leverage Sildenafil Citrate’s high selectivity as a cGMP-specific phosphodiesterase type 5 inhibitor to dissect vascular smooth muscle relaxation, apoptosis regulation, and proteoform-specific signaling. This guide details optimized experimental workflows, troubleshooting strategies, and actionable insights from cutting-edge proteomics studies, ensuring robust, reproducible results for advanced vascular and cellular research.

• PLK1-Dependent Control of p31comet in Mitotic Checkpoint Dis

  2026-04-29

  This study elucidates how Polo-like kinase 1 (PLK1) regulates the mitotic checkpoint component p31comet by direct phosphorylation, thereby modulating the disassembly of mitotic checkpoint complexes (MCC) and ensuring accurate chromosome segregation. The findings reveal a negative regulatory mechanism by which PLK1 prevents premature MCC disassembly, offering key insights for cell cycle and cancer biology research.

15591 records 1/1040 page Next 12345 下5页 Last page